Blueprint Medicines Corporation

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (S…

Biotechnology

US, Cambridge [HQ]

Overview
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Blueprint Medicines Corporation to fulfill lobbying activities in the United States of America.

Blueprint Medicines Corporation has no lobbying expenses in our database.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
No data